Skip to main content

Table 2 Clinical and pathological variables and the expression of SKA3 in 40 cases of cervical cancer

From: SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway

Parameters

Expression of SKA3

p-value

Low

High

Age (years)

0.3598

 ≥ 50

2 (5%)

15 (37.5%)

 

 < 50

4 (10%)

19 (47.5%)

 

TNM stage

0.999

 I + II

6 (15%)

32 (80%)

 

 III + IV

0 (0%)

2 (5%)

 

Clinical stage

0.999

 I + II

5 (12.5%)

29 (72.5%)

 

 III + IV

1 (2.5%)

5 (12.5%)

Â